Navigation Links
Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
Date:5/10/2013

ain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the regulatory review of BELVIQ; and Arena's focus, plans, goals, strategy, expectations, research and development programs, and ability to discover and develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: risks related to commercializing drugs, including regulatory, manufacturing and supply issues and the availability of BELVIQ and pace of market acceptance; cash and revenues generated from BELVIQ, including the impact of competition; Arena's revenues will be based in part on management's estimates, judgment and accounting policies, and incorrect estimates or disagreement regarding Arena's estimates or accounting policies may result in changes to Arena's guidance or previously reported results; the timing and outcome of regulatory review is uncertain, and BELVIQ may not be approved for marketing when expected or ever by any other regulatory agency; regulatory decisions in one territory may impact regulatory decisions in other territories and Arena's business prospects; government and commercial reimbursement and pricing decisions; risks related to relying on collaborative arrangements; the timing and receipt of payments and fees, if any, from collaborators; the entry into or modification or termination of collaborative arrangements; unexpected or unfavorable new data; nonclinical and clinical data is voluminous and detailed, and regulatory agencies may interpret or weigh the importance of data differently and reach different conclusions than Arena or others, request additional informa
'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BIOCOM Applauds Arena Pharmaceuticals Commitment to Innovation, Contributions to Southern California Life Science Community
2. Carena Launches 24/7 Virtual Care Delivery Service for Hospital Systems and Primary Care Clinics
3. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
4. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2
5. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
6. Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
7. Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
8. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Monday, March 4
9. Proposed Regulatory Uniformity to Boost Venture Capital Investments in Healthcare Arena, Says Frost & Sullivan
10. Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
11. Arena Pharmaceuticals and Ildong Pharmaceutical Enter Into Co-Development and License Agreement for Temanogrel, a Novel Agent for Thrombotic Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... , Oct. 17, 2014   DaVita ... ), one of the nation,s largest and most ... DaVita University Academy – the company,s award-winning, leadership ... Nearly 2,000 DaVita teammates from around the globe ... DaVita University Academy is a two-day one-of-a-kind ...
(Date:10/16/2014)... -- Cepheid (Nasdaq: CPHD ) today reported revenues ... representing growth of 15% from $100.1 million for the ... quarter of 2014 was $(7.2) million, or $(0.10) per ... or $(0.02) per share, in the third quarter of ... of debt discount and transaction costs, and amortization of ...
(Date:10/16/2014)... 16, 2014 Eight finalists, all representing outstanding ... present their proposals for a chance to compete for ... Sheikh Zayed Institute Second Annual Pediatric Surgical Innovation Symposium ... on Friday, Oct. 24, 2014. Selected from ... the US and internationally, the finalists are: ...
Breaking Medicine Technology:DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 2DaVita HealthCare Partners Celebrates New-Teammate Training and Leadership Milestone 3Cepheid Reports 2014 Third Quarter Results 2Cepheid Reports 2014 Third Quarter Results 3Cepheid Reports 2014 Third Quarter Results 4Cepheid Reports 2014 Third Quarter Results 5Cepheid Reports 2014 Third Quarter Results 6Cepheid Reports 2014 Third Quarter Results 7Cepheid Reports 2014 Third Quarter Results 8Cepheid Reports 2014 Third Quarter Results 9Cepheid Reports 2014 Third Quarter Results 10Cepheid Reports 2014 Third Quarter Results 11Cepheid Reports 2014 Third Quarter Results 12Cepheid Reports 2014 Third Quarter Results 13Cepheid Reports 2014 Third Quarter Results 14Cepheid Reports 2014 Third Quarter Results 15Cepheid Reports 2014 Third Quarter Results 16Cepheid Reports 2014 Third Quarter Results 17Finalists for Children's National Health System pediatric medical device competition announced 2Finalists for Children's National Health System pediatric medical device competition announced 3Finalists for Children's National Health System pediatric medical device competition announced 4
... Software enables clinical-trial researchers, analysts and managers ... around the world, in real-time, SCOTTSDALE, ... a,part of General Dynamics C4 Systems, introduces ... enables hundreds of,researchers, analysts and managers to ...
... Results, LAUSANNE, Switzerland, April 28 ... specialist,focusing on serious medical conditions, particularly oncology, ... study with Debio 025, a selective,cyclophilin (Cyp) ... C (HCV) effect. Data indicates that Debio ...
Cached Medicine Technology:New CoMotion(R) Trials Software by General Dynamics Enables Rapid, Interactive Sharing of Real-time Data for Clinical Trials 2Clinical Update - Debio 025 in Hepatitis C 2Clinical Update - Debio 025 in Hepatitis C 3
(Date:10/18/2014)... New York (PRWEB) October 18, 2014 ... IUD caused women to sustain serious injuries when it ... continue to mount in U.S. courts, Bernstein Liebhard LLP ... the U.S. Judicial Panel on Multidistrict Litigation (JPML) on ... pending in the multidistrict litigation underway in the U.S. ...
(Date:10/18/2014)... One major trend upcoming in this market ... are making efforts to encourage people to donate organs. ... donation process more transparent and easy. , Analysts forecast ... grow at a CAGR of 16.85 percent over the ... major drivers in the market is an increase in ...
(Date:10/18/2014)... 2014 Risperdal lawsuits ( http://www.risperdallawsuitcenter.com/ ... litigation now underway in Pennsylvania’s Philadelphia Court of ... court documents, 888 product liability claims have been ... patients who allegedly developed serious side effects, ... use of the atypical antipsychotic medication. (In Re: ...
(Date:10/18/2014)... Even determined dieters can fail if they don,t have ... Their new study included 240 obese people. All ... risk factors that increase the risk of heart disease, ... doctors to make lifestyle changes, including improved eating, the ... a clinical trial comparing two dietary interventions: the ...
(Date:10/18/2014)... 18, 2014 As is known to ... webmasters to build websites. Recently, Best Cheap Hosting USA ... announced that Lunarpages Hosting, Bluehost and JustHost are among ... is not so easy to find a good ASP.NET ... hosting features, uptime, server speed and customer support. People ...
Breaking Medicine News(10 mins):Health News:Mirena Lawsuit Filings Grow, as Claims Pending in Federal Litigation Exceed 1,000, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuit Filings Grow, as Claims Pending in Federal Litigation Exceed 1,000, Bernstein Liebhard LLP Reports 3Health News:Mirena Lawsuit Filings Grow, as Claims Pending in Federal Litigation Exceed 1,000, Bernstein Liebhard LLP Reports 4Health News:Organ Preservation Solutions Market to Grow at 16.85% CAGR to 2018 Forecast a New Research Report at Sandlerresearch.org 2Health News:Organ Preservation Solutions Market to Grow at 16.85% CAGR to 2018 Forecast a New Research Report at Sandlerresearch.org 3Health News:Organ Preservation Solutions Market to Grow at 16.85% CAGR to 2018 Forecast a New Research Report at Sandlerresearch.org 4Health News:Risperdal Lawsuits Mount, as Claims in Pennsylvania Litigation Near 900, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Mount, as Claims in Pennsylvania Litigation Near 900, Bernstein Liebhard LLP Reports 3Health News:Dieters May Be Thwarted by Absence of Healthy Foods 2
... medicine specialist at the University at Buffalo has shown that ... who have low sperm count and low percentage sperm motility. ... a synthetic chemical called AM-1346. After incubation, there was a ... semen, results showed. ,Lani Burkman, Ph.D., and colleagues ...
... Who is too old to receive a lung transplant? ... was there a clear answer when the guidelines for lung ... best clinical data then available,” explained Dr. Philip W. Smith, ... Virginia Health System. ,Since lung transplantation (LTX) was ...
... urination during sleep, and is a major problem for children ... bedwetting (nocturnal enuresis) respond to desmopressin, 30% do not. ... that nighttime urine of these children who do not respond ... that this may possibly be due to an imbalance of ...
... in cities or move there from rural areas are more likely ... suffer from this eating disorder.It is a known fact that she ... teenager. ,Bulimia is an eating disorder in which young ... or purging. This study has observed a startling correlation between cases ...
... 23- year- old gay man died of meningitis C in ... meningitidis.// It occurs rarely in Canada and is usually ... has a record of 10 to 15 per cent fatality ... problems, such as deafness and mental retardation. ,Public ...
... UN population fund report has shown, in India, a majority ... hence vulnerable to HIV.// Therefore, there is a definite need ... woman, as the prevalent male-controlled methods are not even 20 ... HIV/AIDS may be provided by over-the-counter microbicides, which are gels, ...
Cached Medicine News:Health News:New Compound May Improve Fertility in Smokers 2Health News:New Compound May Improve Fertility in Smokers 3Health News:Elderly Lung Transplant Patients More Likely to Survive 2Health News:Elderly Lung Transplant Patients More Likely to Survive 3Health News:Hope For Bedwetting Children 2Health News:Hope For Bedwetting Children 3Health News:Hope For Bedwetting Children 4
Glass Whole Blood Tube with K3EDTA...
... Tissue transglutaminase (tTg) is a ubiquitous ... proteins. Tissue transglutaminase is also the ... the endomysial antibody immunofluorescence (EMA) tests ... Anti-tTg IgA and IgG serologic tests ...
... staff gets the training it needs with ... System and Human Capital Management System in ... requirements for JCAHO and HIPAA, understanding compliance ... or developing skills through continuing education courses, ...
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
Medicine Products: